Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Understanding when it’s too late to start retirement planning is crucial for your financial health. Take action to secure your future now.
19,461 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
XRP is down in a shifting crypto market, but analysts point to three catalysts that could trigger a short-term reboun...
As tariff risk looms into Q3, corporate treasuries are testing prediction markets to hedge potential losses. The move...
SpaceX has surged into the spotlight on Hyperliquid, driving the spacex most popular trade narrative. This guide digs...
As the CLARITY Act advances, these crypto tokens could see renewed investor interest. Grayscale highlights revenue-ge...
Meta is pursuing a new play-money prediction market, Arena, designed to test engagement and data signals while naviga...
A former NASDAQ chief warns that SpaceX’s unprecedented lockup could unlock roughly $800 billion in stock by October,...
A shadowy hosting network in Russia reportedly kept cybercrime online, driving millions in losses. This guide explain...
Walmart reports a stronger holiday quarter as wealthier shoppers joined the rush, lifting overall sales and online gr...
Navitas Semiconductor NVTS reports quarterly results that show revenue growth but ongoing margin pressure. Investors ...
Ripple ETFs post a tepid week of inflows while XRP clings close to $1.40, as traders wrestle with whether the initial...
As Magnachip heads into 2025 earnings season, investors want clarity on revenue growth, margins, and capital allocati...